AI in drug discovery: the future is near
The Register - 22-Jan-2025Machine learning promises faster, cheaper, and more effective treatments
Join the club for FREE to access the whole archive and other member benefits.
Company developing AI systems for solving problems
Google DeepMind brings together two of the world’s leading AI labs — Google Brain and DeepMind — into a single, focused team led by our CEO Demis Hassabis. Over the last decade, the two teams were responsible for some of the biggest research breakthroughs in AI, many of which underpin the flourishing AI industry we see today.
DeepMind started in 2010, with an interdisciplinary approach to building general AI systems. The research lab brought together new ideas and advances in machine learning, neuroscience, engineering, mathematics, simulation and computing infrastructure, along with new ways of organizing scientific endeavors.
The lab achieved early success by pioneering the field of deep reinforcement learning - a combination of deep learning and reinforcement learning - and using games to test its systems. One of its early breakthroughs was a program called DQN, which learned to play 49 different Atari games from scratch just by observing the raw pixels on the screen and being told to maximize the score.
Visit website: https://deepmind.google/
Details last updated 29-Nov-2019
Machine learning promises faster, cheaper, and more effective treatments
AI transforms how we understand and target proteins
Balancing productivity gains with the risk of low-quality research
AlphaProteo redefines protein design with groundbreaking AI accuracy
The breakthrough could revolutionize drug discovery and disease treatment
AlphaMissense is a game-changer in genetic research for human health
Building from Deepmind's AI research, Isomorphic promises medical breakthroughs
Will help in developing designer meds, better crops & 'green enzymes' to counter pollution
People's eye changes over 10 years were correlated with the emergence of Alzheimer’s disease
Lab results to the right doctors at the right time can improve patient's outcome
This improvisation was regarded as historical 'turning point' for AI
This A.I reports over 50 different eye diseases with a 94% accuracy
Over 150 firms agreed against developing A.I-based weapons, governments should be next
Veterans Affairs has announced a research partnership with Alphabet subsidiary DeepMind. Will us...
Crunched data from thousands of retinal scans to train an AI algorithm. Analyses them for signs ...
GlaxoSmithKline employs online technology and a data algorithm developed by F1’s elite McLaren Ap...
Seeking to make precision cancer therapy available to all. Currently, volume of research require...
Ray Kurzweil published The Singularity Is Near in 2006 – as technology accelerates at an exponent...
In Deep Medicine, leading physician Eric Topol reveals how artificial intelligence can help
Mustafa Suleyman CBE is a British entrepreneur, activist and, most notably, the co-founder and Head of Applied AI at DeepMind